Considering the high potency of ecnoglutide, it might also serve as a viable option for individuals who do not achieve sufficient weight reduction with existing GLP-1 receptor agonists at their approved doses or need to achieve a larger reduction in bodyweight, Ji added
Brenk R, Schipani A, James D, Krasowski A, Gilbert IH, Frearson J, et al
Additionally, a recent analysis suggests that up to 40% of the weight loss achieved with GLP-1 medications is due to muscle loss
Similar content being viewed by others Introduction Epigenetic regulation of gene expression refers to chromatin-based mechanisms that do not introduce changes in the DNA sequence per se and is not necessarily heritable
It is a GLP-1 receptor agonist and works by stimulating insulin secretion, suppressing glucagon secretion, reducing appetite, and slowing gastric emptying
Previous studies have shown that restricting the analyzed population can mitigate indication bias [21]